venous thromboembolism industry

Venous Thromboembolism Market Worth $2.87 Billion By 2028 CAGR Of 4.2% within Forecast Period 2024-2033

2nd April 2024 - by Top PR News

Overview and Scope Venous thromboembolism (VTE) refers to a medical condition characterized by the formation of blood clots within the veins, which can lead to potentially serious or life-threatening complications. …

Healthcare

Respiratory Disease Vaccine Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends|Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC

1st April 2024 - by Top PR News

Overview and Scope Respiratory diseases refer to a wide range of conditions that affect the airways and lungs, leading to respiratory symptoms and impaired breathing. Respiratory disease vaccine refers to …